Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
OA13 - Evolving Epidemiology of Lung Cancer Beyond Tobacco
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Epidemiology
- Moderators:Matthew T Warkentin, Hilary A Robbins
-
+
Session Moderator
10:47 - 10:57 | Presenter: Matthew T Warkentin
- Abstract
Loading... -
+
Session Moderator
10:47 - 10:57 | Presenter: Hilary A Robbins
- Abstract
Loading... -
+
OA13.01 - Session Introduction
10:45 - 10:46 | Presenter: Matthew T Warkentin
- Abstract
Loading... -
+
OA13.02 - Session Introduction
10:46 - 10:47 | Presenter: Hilary A Robbins
- Abstract
Loading... -
+
OA13.03 - Evaluation of Outdoor Air Pollution Exposure (PM2.5) In Female Non-smoking Lung Cancer Patients
10:47 - 10:57 | Presenter: Renelle L Myers
- Abstract
Loading... -
+
OA13.04 - Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study
10:57 - 11:07 | Presenter: Miguel Garcia Pardo
- Abstract
Loading... -
+
OA13.05 - Lung Cancer Risk Prediction Nomogram in Chinese Female Non-smokers
11:07 - 11:17 | Presenter: Lanwei Guo
- Abstract
Loading... -
+
OA13.06 - Changing Patterns of Lung Cancer Histology in an Asbestos Exposed Population
11:17 - 11:27 | Presenter: Chellan Kumarasamy
- Abstract
Loading... -
+
OA13.07 - Discussant
11:27 - 11:37 | Presenter: Chang-Chuan Chan
- Abstract
Loading... -
+
OA13.08 - Live Q&A
11:37 - 11:45
- Abstract
Loading...
-
+
OA14 - New Techniques to Improve Outcome in Early Stage NSCLC Patients Treated with Surgery or Radiotherapy
- 12:00 - 13:00
- 8/09/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Early Stage Non-small Cell Lung Cancer
- Moderators:Paul Van Schil, Fabio Moraes
-
+
Session Moderator
12:00 - 12:00 | Presenter: Paul Van Schil
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: Fabio Moraes
- Abstract
Loading... -
+
OA14.01 - Session Introduction
12:00 - 12:01 | Presenter: Paul Van Schil
- Abstract
Loading... -
+
OA14.02 - Session Introduction
12:01 - 12:02 | Presenter: Fabio Moraes
- Abstract
Loading... -
+
OA14.04 - Chest Wall Toxicity after Individualized Stereotactic Ablative Radiotherapy for Lung Tumors
12:02 - 12:12 | Presenter: Brianna Lau
- Abstract
Loading... -
+
OA14.05 - Intraoperative Molecular Imaging Guided Resection of CEACAM5+ Lung Tumors: First In-Human SGM-101 Lung Cancer Surgical Trial
12:12 - 12:22 | Presenter: Feredun Azari
- Abstract
Loading... -
+
OA14.06 - T-Cell Dynamics in Response to Neoadjuvant Atezolizumab in Early NSCLC by Antigen Response and T-Cell Receptor Sequencing
12:22 - 12:32 | Presenter: Filiz Oezkan
- Abstract
Loading... -
+
OA14.07 - Discussant
12:32 - 12:42 | Presenter: Brendon Stiles
- Abstract
Loading... -
+
OA14.08 - Live Q&A
12:42 - 13:00
- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- 14:30 - 15:30
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Moderators:Pilar Garrido, António Araújo
-
+
Session Moderator
14:32 - 00:00 | Presenter: Pilar Garrido
- Abstract
Loading... -
+
Session Moderator
14:32 - 00:00 | Presenter: António Araújo
- Abstract
Loading... -
+
OA15.01 - Session Introduction
14:30 - 14:31 | Presenter: Pilar Garrido
- Abstract
Loading... -
+
OA15.02 - Session Introduction
14:31 - 14:32 | Presenter: António Araújo
- Abstract
Loading... -
+
OA15.03 - Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+ NSCLC: Primary Analysis from JAVELIN Lung 100
14:32 - 14:42 | Presenter: Martin Reck
- Abstract
Loading... -
+
OA15.04 - Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC
14:42 - 14:52 | Presenter: Solange Peters
- Abstract
Loading... -
+
OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy
14:52 - 15:02 | Presenter: Benjamin Besse
- Abstract
Loading... -
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Presenter: Delvys Rodriguez-Abreu
- Abstract
Loading... -
+
OA15.07 - Discussant
15:12 - 15:22 | Presenter: Puey Ling Chia
- Abstract
Loading... -
+
OA15.08 - Live Q&A
15:22 - 15:30
- Abstract
Loading...
